INSPIRE VETERINARY PARTNERS, INC. 8-K

What Happened Inspire Veterinary Partners, Inc. (IVP) filed an 8-K reporting that Nasdaq’s Hearing Panel denied the company’s appeal on January 20, 2026, and the company’s Class A common stock was suspended from trading on The Nasdaq Capital Market at the open on January 21, 2026 and will be delisted. Nasdaq had previously notified the company on November 13, 2025 that it was not in compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)). The company received approval for its common stock to trade on the OTCQB Venture Market under the symbol “IVPR,” and trading on the OTCQB began on January 21, 2026. The company expects Nasdaq to file a Form 25 to remove the securities from Nasdaq listing and registration and stated it intends to continue filing periodic and current reports with the SEC.

Key Details

• Nasdaq notice received November 13, 2025 for failure to meet minimum bid price under Rule 5550(a)(2).
• Company requested a hearing; hearing was held January 13, 2026; Panel denied continuation January 20, 2026.
• Class A common stock (par value $0.0001) suspended from Nasdaq and delisted effective January 21, 2026.
• Common stock began trading on the OTCQB as “IVPR” on January 21, 2026; company expects Nasdaq to file Form 25 to finalize removal.

Why It Matters Delisting from Nasdaq typically reduces a stock’s visibility and liquidity and can lead to wider bid-ask spreads and fewer institutional investors. Moving to the OTCQB allows trading to continue but on a less prominent marketplace with different listing standards. Importantly, Inspire said it will continue to provide SEC periodic and current reports, so investors will still have access to the company’s required public filings.